150 related articles for article (PubMed ID: 22301950)
1. The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat.
Pettersen JC; Pruimboom-Brees I; Francone OL; Amacher DE; Boldt SE; Kerlin RL; Ballinger WE
Toxicol Pathol; 2012 Apr; 40(3):435-47. PubMed ID: 22301950
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
3. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
4. Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscle.
De Souza AT; Cornwell PD; Dai X; Caguyong MJ; Ulrich RG
Toxicol Sci; 2006 Aug; 92(2):578-86. PubMed ID: 16707586
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
6. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
[TBL] [Abstract][Full Text] [Related]
7. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
8. PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium.
Egerod FL; Brünner N; Svendsen JE; Oleksiewicz MB
J Appl Toxicol; 2010 Mar; 30(2):151-62. PubMed ID: 19757489
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.
Gelosa P; Banfi C; Gianella A; Brioschi M; Pignieri A; Nobili E; Castiglioni L; Cimino M; Tremoli E; Sironi L
J Pharmacol Exp Ther; 2010 Nov; 335(2):324-31. PubMed ID: 20671072
[TBL] [Abstract][Full Text] [Related]
10. Comparative study between the effect of the peroxisome proliferator activated receptor-alpha ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5'-AMP-activated protein kinase-alpha1 in high-fat fed rats.
Motawi TM; Hashem RM; Rashed LA; El-Razek SM
J Pharm Pharmacol; 2009 Oct; 61(10):1339-46. PubMed ID: 19814866
[TBL] [Abstract][Full Text] [Related]
11. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.
Ohta T; Masutomi N; Tsutsui N; Sakairi T; Mitchell M; Milburn MV; Ryals JA; Beebe KD; Guo L
Toxicol Pathol; 2009 Jun; 37(4):521-35. PubMed ID: 19458390
[TBL] [Abstract][Full Text] [Related]
12. PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742.
Faiola B; Falls JG; Peterson RA; Bordelon NR; Brodie TA; Cummings CA; Romach EH; Miller RT
Toxicol Sci; 2008 Oct; 105(2):384-94. PubMed ID: 18593727
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.
Delaney J; Hodson MP; Thakkar H; Connor SC; Sweatman BC; Kenny SP; McGill PJ; Holder JC; Hutton KA; Haselden JN; Waterfield CJ
Arch Toxicol; 2005 Apr; 79(4):208-23. PubMed ID: 15838709
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats.
Tonomura Y; Mori Y; Torii M; Uehara T
Toxicology; 2009 Dec; 266(1-3):48-54. PubMed ID: 19854236
[TBL] [Abstract][Full Text] [Related]
15. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.
Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J
Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115
[TBL] [Abstract][Full Text] [Related]
18. Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity.
Kochansky CJ; Lyman MJ; Fauty SE; Vlasakova K; D'mello AP
Lipids; 2018 Oct; 53(10):947-960. PubMed ID: 30592062
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
